Reply to “Topical ionic contra-viral therapy comprised of digoxin and furosemide as a potential novel treatment approach for common warts”

Absract

I read with great interest a preliminary study on new treatment for common warts conducted by Kolk et al.¹ The authors studied, for the first time, the clinical response of common warts to topical application of a fixed dose of 980 mg topical gel containing 0.125% (w/w) digoxin and 0.125% (w/w) furosemide for 7 consecutive days on the patients' lower back. Basically, topical therapy for a common dermatosis is generally welcomed particularly if showed a higher degree of safety profile and less potential off-target adverse effects. Though promising, few queries should be addressed by the authors.

This article is protected by copyright. All rights reserved.